Furthermore, CD133 knockdown or Src inhibition abrogates the increasing levels of N-cadherin and vimentin induced by CD133 overexpression in head and neck cancer cell lines, whereas promoting epithelial morphological acquisition characterized by E-cadherin and CK18 epithelial marker upregulation [75]. This evidence concerns the gene PROM1 and head and neck cancer.